GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biomerica Inc (NAS:BMRA) » Definitions » Cyclically Adjusted FCF per Share

Biomerica (Biomerica) Cyclically Adjusted FCF per Share : $-0.26 (As of Feb. 2024)


View and export this data going back to 1978. Start your Free Trial

What is Biomerica Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Biomerica's adjusted free cash flow per share for the three months ended in Feb. 2024 was $-0.108. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.26 for the trailing ten years ended in Feb. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -35.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -38.30% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -26.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Biomerica was 30.70% per year. The lowest was -49.40% per year. And the median was -14.90% per year.

As of today (2024-05-26), Biomerica's current stock price is $0.626. Biomerica's Cyclically Adjusted FCF per Share for the quarter that ended in Feb. 2024 was $-0.26. Biomerica's Cyclically Adjusted Price-to-FCF of today is .


Biomerica Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Biomerica's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomerica Cyclically Adjusted FCF per Share Chart

Biomerica Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.07 -0.10 -0.16 -0.18 -0.25

Biomerica Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.24 -0.25 -0.25 -0.25 -0.26

Competitive Comparison of Biomerica's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Biomerica's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomerica's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biomerica's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Biomerica's Cyclically Adjusted Price-to-FCF falls into.



Biomerica Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biomerica's adjusted Free Cash Flow per Share data for the three months ended in Feb. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=-0.108/130.9299*130.9299
=-0.108

Current CPI (Feb. 2024) = 130.9299.

Biomerica Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201405 -0.023 100.373 -0.030
201408 0.019 100.352 0.025
201411 0.003 99.635 0.004
201502 -0.067 99.032 -0.089
201505 -0.012 100.333 -0.016
201508 -0.027 100.548 -0.035
201511 -0.033 100.135 -0.043
201602 0.025 100.040 0.033
201605 -0.005 101.355 -0.006
201608 -0.009 101.617 -0.012
201611 -0.029 101.829 -0.037
201702 -0.010 102.779 -0.013
201705 -0.039 103.256 -0.049
201708 -0.017 103.587 -0.021
201711 -0.032 104.072 -0.040
201802 -0.060 105.052 -0.075
201805 -0.043 106.148 -0.053
201808 -0.092 106.383 -0.113
201811 -0.030 106.338 -0.037
201902 -0.031 106.649 -0.038
201905 -0.109 108.048 -0.132
201908 -0.002 108.245 -0.002
201911 -0.037 108.519 -0.045
202002 -0.048 109.139 -0.058
202005 -0.323 108.175 -0.391
202008 -0.144 109.662 -0.172
202011 -0.112 109.793 -0.134
202102 -0.123 110.968 -0.145
202105 -0.088 113.576 -0.101
202108 0.000 115.421 0.000
202111 0.103 117.269 0.115
202202 0.182 119.703 0.199
202205 -0.333 123.323 -0.354
202208 -0.123 124.958 -0.129
202211 -0.092 125.607 -0.096
202302 -0.128 126.928 -0.132
202305 -0.059 128.314 -0.060
202308 -0.103 129.538 -0.104
202311 -0.051 129.548 -0.052
202402 -0.108 130.930 -0.108

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Biomerica  (NAS:BMRA) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Biomerica Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Biomerica's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomerica (Biomerica) Business Description

Traded in Other Exchanges
N/A
Address
17571 Von Karman Avenue, Irvine, CA, USA, 92614
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.
Executives
John P. Kenny director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Zacharys Irani director, officer: Cheif Executive Officer 17571 VON KARMAN AVE., IRVINE CA 92614
Gary Lu officer: Chief Financial Officer 12136 AHERN CT, TUSTIN CA 92782
Allen Barbieri director
Catherine Coste director 966 OCHO RIOS DR, DANVILLE CA 94526
David Moatazedi director C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Steven Sloan officer: Chief Financial Officer 114 TERRAPIN, IRVINE CA 92618
Mark A Sirgo director C/O BIODELIVERY SCIENCES INTERNATIONAL, 801 CORPORATE CENTER DRIVE -SUITE 210, RALEIGH NC 27607
Francis Cano director 11 ACORN LANE, LOS ALTOS CA 94022
Francis E Capitanio officer: President-diagnostics 1533 MONROVIA AVENUE, NEWPORT BEACH CA 92663
Janet Moore director, 10 percent owner, officer: Secretary 1533 MUNROVIA AVE, NEWPORT BEACH CA 92663
Jane Emerson director 1533 MONROVIA AVE, NEWPORT BEACH CA 92663
William Snider other: Greater than 5% holder 4800 MONTGOMERY LANE, SUITE 230, BETHESDA MD 20814
Broadoak Fund The other: Greater than 5% holder 7201 WISCONSIN AVE. #630, BETHESDA MD 20814
John Roehm director 1533 MONROVIA AVE., NEWPORT BEACH CA 92663

Biomerica (Biomerica) Headlines

From GuruFocus

Biomerica to Participate at BTIG Biotech Conference

By PurpleRose PurpleRose 07-13-2022

Biomerica Reports Q3 Fiscal 2023 Results

By sperokesalga sperokesalga 04-14-2023